Among the cancer lines tested, leukemia and lung cancer cell lines were most affected by GLUT3 inhibitors G3iB-G3iE, pointing to a more significant reliance of these cells on glucose transport by Class 1 GLUTs. The gene discussed is SLC2A3; the disease is lung carcinoma.